🏥 治験ポータル
← 治験一覧に戻る

子宮頸がんステージIの患者に対する化学療法および放射線療法(手術の有無を問わず)

基本情報

NCT ID
NCT00054067
ステータス
中止
試験のフェーズ
第3相
試験タイプ
介入
目標被験者数
-
治験依頼者名
GOG Foundation

概要

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which regimen of radiation therapy combined with chemotherapy, with or without surgery, is more effective in treating early cancer of the cervix. PURPOSE: Randomized phase III trial to compare the effectiveness of surgery followed by different regimens of radiation therapy and chemotherapy with that of chemotherapy and radiation therapy alone in treating patients who have stage I cancer of the cervix.

対象疾患

Cervical Cancer

介入

cisplatin(DRUG)
adjuvant therapy(PROCEDURE)
conventional surgery(PROCEDURE)
brachytherapy(RADIATION)
radiation therapy(RADIATION)

実施施設 (1)

鹿児島市立病院

Kagoshima, Japan